Aurobindo Pharma has incorporated a wholly owned subsidiary, Engenra Biologics, to expand its contract manufacturing operations.

Besides contract manufacturing, the objective is also to expand other pharmaceutical manufacturing operations, Aurobindo Pharma said on Tuesday in a filing.